1. Home
  2. CCL vs TEVA Comparison

CCL vs TEVA Comparison

Compare CCL & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carnival Corporation

CCL

Carnival Corporation

HOLD

Current Price

$30.84

Market Cap

34.2B

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$31.41

Market Cap

30.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCL
TEVA
Founded
1972
1901
Country
United States
Israel
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.2B
30.2B
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
CCL
TEVA
Price
$30.84
$31.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
9
Target Price
$35.53
$32.11
AVG Volume (30 Days)
21.4M
9.3M
Earning Date
12-19-2025
01-28-2026
Dividend Yield
1.95%
N/A
EPS Growth
40.51
N/A
EPS
2.02
0.62
Revenue
$26,622,000,000.00
$16,776,000,000.00
Revenue This Year
$5.33
$4.62
Revenue Next Year
$3.59
$0.34
P/E Ratio
$15.21
$51.14
Revenue Growth
6.40
0.02
52 Week Low
$15.07
$12.47
52 Week High
$32.89
$31.99

Technical Indicators

Market Signals
Indicator
CCL
TEVA
Relative Strength Index (RSI) 64.71 77.93
Support Level $30.27 $31.17
Resistance Level $32.89 $31.99
Average True Range (ATR) 1.07 0.58
MACD 0.32 -0.07
Stochastic Oscillator 72.07 81.76

Price Performance

Historical Comparison
CCL
TEVA

About CCL Carnival Corporation

Carnival is the largest global cruise company, with more than 90 ships in service. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It recently folded its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted 14 million guests in 2024.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: